Collins Sean R, Douglass Adam, Vale Ronald D, Weissman Jonathan S
Howard Hughes Medical Institute, Department of Cellular and Molecular Pharmacology, University of California, San Francisco, USA.
PLoS Biol. 2004 Oct;2(10):e321. doi: 10.1371/journal.pbio.0020321. Epub 2004 Sep 21.
Abundant nonfibrillar oligomeric intermediates are a common feature of amyloid formation, and these oligomers, rather than the final fibers, have been suggested to be the toxic species in some amyloid diseases. Whether such oligomers are critical intermediates for fiber assembly or form in an alternate, potentially separable pathway, however, remains unclear. Here we study the polymerization of the amyloidogenic yeast prion protein Sup35. Rapid polymerization occurs in the absence of observable intermediates, and both targeted kinetic and direct single-molecule fluorescence measurements indicate that fibers grow by monomer addition. A three-step model (nucleation, monomer addition, and fiber fragmentation) accurately accounts for the distinctive kinetic features of amyloid formation, including weak concentration dependence, acceleration by agitation, and sigmoidal shape of the polymerization time course. Thus, amyloid growth can occur by monomer addition in a reaction distinct from and competitive with formation of potentially toxic oligomeric intermediates.
丰富的非纤维状寡聚中间体是淀粉样蛋白形成的一个常见特征,并且有人提出,在某些淀粉样蛋白疾病中,这些寡聚体而非最终的纤维才是有毒物质。然而,这些寡聚体究竟是纤维组装的关键中间体,还是通过另一条可能可分离的途径形成,仍不清楚。在此,我们研究了酵母朊病毒蛋白Sup35的聚合过程。在没有可观察到的中间体的情况下会发生快速聚合,并且靶向动力学和直接单分子荧光测量均表明,纤维通过单体添加而生长。一个三步模型(成核、单体添加和纤维断裂)准确地解释了淀粉样蛋白形成的独特动力学特征,包括弱浓度依赖性、搅拌加速以及聚合时间进程的S形。因此,淀粉样蛋白的生长可以通过单体添加在一个与潜在有毒寡聚中间体形成不同且相互竞争的反应中发生。